Program

Program

The program will include sessions on:

  • Small molecule modulation of stem cell differentiation
  • Development of disease models using gene editing of hESCs and patient-derived iPSCs
  • Instrumental methods for phenotypic chemical library screening
  • 3D cell culture models and organoids in disease modelling
  • Future uses of stem cell technology in the pharmaceutical industry

Full program will be available from early 2018.